Per- and polyfluoroalkyl substances (PFAS), often called forever chemicals because of their long-lasting presence in humans and the environment, are commonly found in consumer and industrial products. When Brown University ...
Sep 14, 2026
0
3
Combining the targeted therapy olaparib with an additional immunotherapy may improve immune response in a subgroup of patients with metastatic castration-resistant prostate cancer who responded poorly to initial treatment, ...
Sep 10, 2026
0
7
Prostate cancer is the second most common form of cancer among men globally. Yet, we still know relatively little about why the disease develops or why some men live with it for years while it progresses aggressively in others.
Sep 9, 2026
0
10
New research in the International Journal of Clinical Practice suggests that workplace psychological stress may impair erectile function in young men by affecting certain stress-management pathways in the brain and reducing ...
Sep 9, 2026
0
6
Many prostate cancers depend on androgen hormones, including testosterone, to grow. That is why treatments for advanced disease often try to reduce testosterone production or block its effects. Now, scientists have identified ...
Sep 7, 2026
0
27
Findings from STAMINA, the largest trial of its kind, published in The Lancet Oncology, show that a purpose-designed lifestyle program offering structured exercise, dietary advice and behavioral support as part of routine ...
Sep 7, 2026
0
71
Every September, Australians are encouraged to ask someone a simple question: "Are you OK?"
Sep 7, 2026
0
6
For patients with nonmetastatic prostate cancer, focal therapy use has remained uncommon across risk groups, and its use was defined as inappropriate in about half of recipients, according to a research letter published online ...
Sep 6, 2026
0
157
Testosterone is having a moment. On social media, it's being lauded for everything from building muscle to gaining wealth and sexual dominance.
Sep 4, 2026
0
8
Men already genetically at risk for the most common form of hair loss have a 7% added risk of losing their hair if they use drugs like Ozempic, Wegovy and Zepbound for type 2 diabetes and obesity, a new study shows.
Sep 3, 2026
0
49
